Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patricia Melville

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
American Journal of Therapeutics|September 23, 2009
High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis: 2-year follow-up (investigational new drug No. 65863)Douglas E Gladstone, Robert Peyster, Edward Baron, et al.
Journal of the Neurological Sciences|April 22, 2006
Effects of donepezil on memory and cognition in multiple sclerosisChristopher Christodoulou, Patricia Melville, William F Scherl, et al.
Journal of the International Neuropsychological Society : JINS|January 9, 2009
Negative affect predicts subsequent cognitive change in multiple sclerosisChristopher Christodoulou, Patricia Melville, William F Scherl, et al.
Journal of the International Neuropsychological Society : JINS|October 11, 2005
Perceived cognitive dysfunction and observed neuropsychological performance: longitudinal relation in persons with multiple sclerosisChristopher Christodoulou, Patricia Melville, William F Scherl, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 21, 2011
Unemployment in multiple sclerosis: the contribution of personality and diseaseLauren B Strober, Christopher Christodoulou, Ralph H B Benedict, et al.
Mucosal Immunology|July 4, 2026
Mucin degradation by Akkermansia muciniphila promotes Alistipes-dependent tryptophan metabolism and Th17-driven autoimmunityXun Lin, Ankita Singh, Xindi Shan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 2, 2021
Nrf2 through Aryl Hydrocarbon Receptor Regulates IL-22 Response in CD4<sup>+</sup> T CellsXun Lin, Suzanne Tawch, Hoi Tong Wong, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
American Journal of Therapeutics|September 23, 2009
High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis: 2-year follow-up (investigational new drug No. 65863)Douglas E Gladstone, Robert Peyster, Edward Baron, et al.
Journal of the Neurological Sciences|April 22, 2006
Effects of donepezil on memory and cognition in multiple sclerosisChristopher Christodoulou, Patricia Melville, William F Scherl, et al.
Journal of the International Neuropsychological Society : JINS|January 9, 2009
Negative affect predicts subsequent cognitive change in multiple sclerosisChristopher Christodoulou, Patricia Melville, William F Scherl, et al.
Journal of the International Neuropsychological Society : JINS|October 11, 2005
Perceived cognitive dysfunction and observed neuropsychological performance: longitudinal relation in persons with multiple sclerosisChristopher Christodoulou, Patricia Melville, William F Scherl, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 21, 2011
Unemployment in multiple sclerosis: the contribution of personality and diseaseLauren B Strober, Christopher Christodoulou, Ralph H B Benedict, et al.
Mucosal Immunology|July 4, 2026
Mucin degradation by Akkermansia muciniphila promotes Alistipes-dependent tryptophan metabolism and Th17-driven autoimmunityXun Lin, Ankita Singh, Xindi Shan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 2, 2021
Nrf2 through Aryl Hydrocarbon Receptor Regulates IL-22 Response in CD4<sup>+</sup> T CellsXun Lin, Suzanne Tawch, Hoi Tong Wong, et al.
Pageof 1